pulmonary-tuberculosis

Documents about pulmonary-tuberculosis

• Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment#908784ClinicalTrials.gov
• Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis#915908ClinicalTrials.gov
• Lung Health After Tuberculosis: Clinical and Functional Assessment in Post Pulmonary Tuberculosis Egyptian Patients.#894629ClinicalTrials.gov
• ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)#1031116ClinicalTrials.gov
• Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis#811598ClinicalTrials.gov
• Pulmonary Aspergillosis in Tuberculosis Patients#674918ClinicalTrials.gov
• Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis#256917ClinicalTrials.gov
• TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment#855887ClinicalTrials.gov
• A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2#967355ClinicalTrials.gov
• Structural and Functional Repercussions of Pulmonary Tuberculosis Sequelae#842176ClinicalTrials.gov
• Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)#836653ClinicalTrials.gov
• Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis#18528ClinicalTrials.gov
• BTZ-043 Dose Evaluation in Combination and Selection#208470ClinicalTrials.gov
• Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081#872092ClinicalTrials.gov
• Point-of-care Triage Test for Active Tuberculosis#217202ClinicalTrials.gov
• A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis#28367ClinicalTrials.gov
• Line Probe Assay Evaluation Study#899976ClinicalTrials.gov
• Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis#872801ClinicalTrials.gov
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid#852496ClinicalTrials.gov
• Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis#876070ClinicalTrials.gov
• Effect of Breathing Exercise on Fatigue in Patients With Pulmonary Tuberculosis#966571ClinicalTrials.gov
• Tuberculosis Cohort Avicenne Hospital#878501ClinicalTrials.gov
• Doxycycline in Human Pulmonary Tuberculosis#917086ClinicalTrials.gov
• Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis#800791ClinicalTrials.gov
• Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis#884440ClinicalTrials.gov
• Global tuberculosis report 2016#184010WHO IRIS
• Respiratory Health and Wellbeing Post Pulmonary Tuberculosis#858967ClinicalTrials.gov
• Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)#871558ClinicalTrials.gov
• Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis#891475ClinicalTrials.gov
• Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis#841307ClinicalTrials.gov
• Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis#881556ClinicalTrials.gov
• Studi Pola Penggunaan Obat Anti Tuberkulosis pada Pasien Tuberkulosis Paru: The Study of Anti Tuberculosis Drugs Used in Pulmonary Tuberculosis Patients#1003917Jurnal Surya Medika (JSM)
• Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis#849487ClinicalTrials.gov
• Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis#411242ClinicalTrials.gov
• Cardiopulmonary Function and Quality of Life in Pulmonary Tuberculosis#855269ClinicalTrials.gov
• Adherence in Pulmonary Tuberculosis Patients Based on King's Interacting Systems Theory#1004707Jurnal Ners
• A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults#846482ClinicalTrials.gov
• Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide#834478ClinicalTrials.gov
• Family Health Tasks Implementation and Medication Adherence of Pulmonary Tuberculosis Patients: A Correlational Study#1005100Jurnal Ners
• ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74#148584ClinicalTrials.gov
• Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)#424242ClinicalTrials.gov
• A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis#909229ClinicalTrials.gov
• A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis#848989ClinicalTrials.gov
• Linezolid Dosing Strategies in Drug-Resistant TB#810954ClinicalTrials.gov
• A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets#905526ClinicalTrials.gov
• Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)#805178ClinicalTrials.gov
• Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)#894455ClinicalTrials.gov
• Relationship Between Proactive Coping and Self-Care Management in Patient with Pulmonary Tuberculosis#1005070Jurnal Ners
• Protocol for clinical diagnosis and empiric treatment of pulmonary tuberculosis in severely burned patients : observations and literature review#361126SUNScholar
• Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis#261313ClinicalTrials.gov